Zomedica Corp. SEC filings ZOMDF
Zomedica Corp. has 482 filings in SEC EDGAR's recent list, going back to Sep 8, 2016. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 27, 2026 | Apr 24, 2026 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 14, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Jun 6, 2025 | — |
| DEFA14A | Additional proxy material | May 30, 2025 | — |
| DEFA14A | Additional proxy material | May 30, 2025 | — |
| DEFA14A | Additional proxy material | May 13, 2025 | — |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Apr 30, 2025 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Feb 20, 2024 | — |
| DEFA14A | Additional proxy material | Feb 6, 2024 | — |
| DEFA14A | Additional proxy material | Jan 31, 2024 | — |
| DEFA14A | Additional proxy material | Jan 26, 2024 | — |
| DEFA14A | Additional proxy material | Jan 24, 2024 | — |
| DEFA14A | Additional proxy material | Jan 17, 2024 | — |
| DEF 14A | Proxy statement | Jan 17, 2024 | Jan 16, 2024 |
| PRE 14A | Preliminary proxy statement | Jan 5, 2024 | Jan 5, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 13, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Jun 7, 2022 |
| DEF 14A | Proxy statement | Jun 21, 2021 | Jul 30, 2021 |
| DEFA14A | Additional proxy material | Sep 14, 2020 | — |
| DEFA14A | Additional proxy material | Aug 27, 2020 | — |
| DEFA14A | Additional proxy material | Aug 20, 2020 | — |
| DEF 14A | Proxy statement | Aug 14, 2020 | Sep 25, 2020 |
| PRE 14A | Preliminary proxy statement | Jul 29, 2020 | Sep 25, 2020 |
| DEF 14A | Proxy statement | Sep 27, 2019 | Nov 5, 2019 |
| DEFA14A | Additional proxy material | Jul 12, 2018 | — |
| DEF 14A | Proxy statement | Jul 5, 2018 | Aug 15, 2018 |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZOMDF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Alberta, Canada
- Headquarters
- Ann Arbor, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1684144
- Former names
- Zomedica Pharmaceuticals Corp. (until Sep 28, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.